CurrentRheuma
Get Weekly

Topic · page 5 of 17

Osteoporosis & bone health

Postmenopausal, male and glucocorticoid-induced osteoporosis, fracture risk assessment and bone density, fragility fractures and their secondary prevention, anti-resorptive and anabolic drugs, treatment sequence and drug holidays

Briefs 161–200 of 659 placed here, newest publication first

Briefs in Osteoporosis & bone health

Newest publication first

  1. Osteoporos Int

    The effectiveness of bisphosphonates vs denosumab in people with dementia or frailty post hip fracture: a multi-database cohort study

    Cohort study

  2. Osteoporos Int

    Moderate-intensity exercise reduces osteoporotic fracture risk in older women: a dose-response analysis from a nationwide Korean cohort

    Cohort study

  3. Osteoporos Int

    Postoperative osteoporosis therapy and risk of re-fracture in elderly patients with hip fractures: a multicenter retrospective cohort study

    Cohort study

  4. Osteoporos Int

    Outcome evaluation of osteoporosis patient education: an observational study comparing an intervention group and matched control group

    Cohort study

  5. JAMA Netw Open

    Neighborhood Deprivation and Days Spent at Home After Fall-Related Hip Fracture

    Cohort study

  6. JAMA Netw Open

    Ultrasound-Guided Regional Anesthesia by Emergency Physicians for Hip Fractures and Delirium: A Randomized Clinical Trial

    Randomized controlled trial

  7. Arthritis Care Res (Hoboken)

    Adipokines and Associations With Incident Osteoporotic Fracture in Patients With Rheumatoid Arthritis

    Cohort study

  8. Osteoporos Int

    Loss of muscle and bone mass with increased adiposity and fractures in patients with chronic obstructive pulmonary disease: A 5-year follow-up cohort study

    Cohort study

  9. Osteoporos Int

    A scoping review of real-world evidence generation methods to estimate the safety of type 2 diabetes medications on fracture risk

    Research article

  10. Osteoporos Int

    Treatment patterns of romosozumab in postmenopausal women with severe osteoporosis in Denmark: findings from the ROmosozumab in Scandinavia real-world Evidence Study (ROSES)

    Cohort study

  11. Osteoporos Int

    Complementary effects of trabecular bone score and hip axis length on fracture risk: the Manitoba BMD Registry

    Cohort study

  12. Osteoporos Int

    What is the association between physical activity and fracture risk in middle-aged adults (aged 30–60): a systematic review and synthesis without meta-analysis (SWIM)

    Meta-analysis

  13. Osteoporos Int

    Anabolic‐steroid therapy after geriatric proximal femur fracture: a level I evidence systematic review and meta-analysis of bone density, functional recovery, and safety

    Meta-analysis

  14. Osteoporos Int

    Degenerative scoliosis may trigger higher incidence of adjacent vertebral fractures following percutaneous vertebroplasty: a clinical evidence-based biomechanical research

    Cohort study

  15. Osteoporos Int

    Fracture trends in Denmark from 1997 to 2021

    Cohort study

  16. Osteoporos Int

    Increased risk of hip and other major osteoporotic fractures within 18 months of lymphoma diagnosis—a national registry study of 36,864 Swedish lymphoma patients

    Cohort study

  17. Osteoporos Int

    Accelerometer-measured weekly and diurnal moderate-to-vigorous physical activity patterns and incident osteoporosis

    Cohort study

  18. Osteoporos Int

    The prospective association between high-density lipoprotein (HDL) cholesterol and risk of incident fractures in the general population

    Cohort study

  19. Osteoporos Int

    Beyond the initial impact: a systematic review of post-traumatic bone loss and its mechanisms

    Meta-analysis

  20. Osteoporos Int

    Explainable opportunistic osteoporosis screening from chest X-rays: a retrospective comparison of foundation models

    Diagnostic or prognostic study

  21. Osteoporos Int

    Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries

    Cohort study

  22. Osteoporos Int

    The association of bone density and hip fracture risk among Asian women

    Cohort study

  23. Osteoporos Int

    The association of loneliness with bone mineral density, osteoporosis, osteopenia, fall, and sarcopenia among older adults: results from Mr. and Ms. Os (Hong Kong) study

    Cohort study

  24. Rheumatology (Oxford)

    Deprivation indices and their association with fragility fractures and bone density: evidence from a large observational cohort

    Cohort study

  25. Osteoporos Int

    A systematic review and meta-analysis of sequential treatment strategies for osteoporosis

    Meta-analysis

  26. Osteoporos Int

    Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis

    Cohort study

  27. Osteoporos Int

    Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study

    Cohort study

  28. Osteoporos Int

    A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis

    Randomized controlled trial

  29. Osteoporos Int

    Prevalence and risk factors of osteoporosis and fragility fractures in aging Hakka women in Taiwan

    Cohort study

  30. Osteoporos Int

    ROMosozumab early experience in female patients with severe osteoporosis in an Italian real-world setting, the ROMEO study

    Cohort study

  31. Osteoporos Int

    Age at diabetes diagnosis and fracture risk in women: a cohort study from the Australian Longitudinal Study on Women’s Health

    Cohort study

  32. Semin Arthritis Rheum

    Reduction of subchondral bone marrow lesions concurrent with early recovery of trabecular bone mineral density in knee osteoarthritis following RANKL inhibitor administration for the treatment of osteoporosis: Implying human osteoporotic osteoarthritis?

    Cohort study

  33. Osteoporos Int

    Personalizing denosumab therapy in postmenopausal Indian women with osteoporosis: predictive role of bone turnover markers and body mass index in determining dosing interval

    Cohort study

  34. Lupus Sci Med

    Potential causal effect of SLE on osteoporosis, and the mediation effect: a Mendelian randomisation study

    Meta-analysis

  35. Osteoporos Int

    Adherence to secondary fracture prevention is associated with reduced risk of subsequent fractures

    Cohort study

  36. Clin Exp Rheumatol

    Drug-induced osteoporosis/osteopenia: a pharmacovigilance analysis using the FDA Adverse Event Reporting System database

    Cohort study

  37. RMD Open

    ‘Fast Ossifier’ in diffuse idiopathic skeletal hyperostosis: a sex-modulated, heterogeneous phenotype with accelerated ossification and early trabecular decline

    Case-control study

  38. Osteoporos Int

    Impact of standard versus cyclic teriparatide and denosumab treatment on trabecular bone score: a post-hoc analysis of a randomized clinical trial

    Secondary analysis

  39. Osteoporos Int

    Should we consider ankle fractures as osteoporotic fractures?

    Cross-sectional study

  40. Clin Exp Rheumatol

    Romosozumab effect on neutrophil-to-lymphocyte ratio in post-menopausal women at high risk of fracture

    Cohort study

All 659 Briefs in ExploreShowing Briefs 161–200 of 659, newest first